ALC:NYSE
Alcon AG
73,60 $
arrow_downward
-0,70%(-0,52) 1D
16 қар., 15:36:33 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
74,35 $
High
74,76 $
Low
73,60 $
Mkt. cap
31,19 млрд
Avg. vol.
2,14 млн
Volume
1,27 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
Open
74,35 $
High
74,76 $
Low
73,60 $
Mkt. cap
31,19 млрд
Avg. vol.
2,14 млн
Volume
1,27 млн
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
483,40 млн
No. of employees
25 мың
News stories
From web sources and news partners
ChartMill
·
31 минут бұрын
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Investing.com
·
39 минут бұрын
Why is SPDR S&P 500 ETF sliding today?
FXStreet
·
3 сағат бұрын
The S&P 500 will find a new leader
Stocktwits
·
3 сағат бұрын
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25 мың
Founded1945
HeadquartersЖенева, Женева, Швейцария
SectorHealth Care
IndustryMedical device
Websitealcon.com